Amneal Pharmaceuticals, Inc. AMRX Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s change in AP?
- Amneal Pharmaceuticals, Inc. (AMRX) reported change in AP of -$124.58M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s change in AP changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s change in AP decreased by 10.6% year-over-year, from -$112.63M to -$124.58M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.